The funding will help bring Progentec’s tool for identifying lupus flare ups and a biomarker-based disease-activity index closer to commercialization.
Progentec Raises Funds to Support Advances in Lupus Detection and Management
OMRF elects four new board members
OMRF named Leigh Ann Albers, Tricia Everest, Ronnie Irani and Dr. Barry Pollard to its board of directors.
OMRF adds three new researchers
The trio of scientists assumed their new positions at the foundation Nov. 1, bringing the total number of OMRF senior scientists to 49.
OMRF welcomes trick-or-treaters from Positive Tomorrows
For the 12th consecutive year, OMRF hosted a Halloween event for more than 70 trick-or-treaters from Positive Tomorrows.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
Fear itself: Unmasking the fight-or-flight response
So, what exactly happens inside your body when things go bump in the night?